Five NASA Scientists Reflect on a Year of Turmoil

To biochemist Nitza Cintron, a member of what she describes as "the NASA family," the Challenger accident brought with it a great sense of loss. As chief of the 75-person Biomedical Laboratories at Johnson Space Center, Cintron believes the accident has had a greater impact on operational responsibilities—supporting shuttle flights—than on basic research. But there are lots of projects that can only be done in space which have been temporarily suspended. Some of Cintron's own researc

Written byRay Spangenburg
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Some of Cintron's own research into the atrial natriuretic factor (ANF) is stymied by the shutdown. Cintron, who joined the Center after completing her doctorate in biochemistry at Johns Hopkins Medical School in 1978, is looking for a possible connection between ANF and the human physiological response to space flight.

So far, she said, they've gotten some nice results. But she added, "researching in space takes time to get a good experimental basis, and we still don't have the whole story." With the shuttle grounded, some of the chapters will not be told soon. "But we'll start up again," promised the 36-year-old Cintron. "No one doubts that."

The problems she has experienced with funding related more to the overall federal deficit, she believes, "Gramm-Rudman and so forth." But Jerry L. Homick, deputy chief of the. Medical Services Division at Johnson, acknowledged that some money for flight-related life science research projects ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies